Subscribe To
INSP / INSP Stock Breaks Out On Massive Sales Growth
INSP News
By Zacks Investment Research
October 31, 2023
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key more_horizontal
By Seeking Alpha
October 25, 2023
Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth
Today, we take a deeper look at Inspire Medical Systems, Inc., a medical device manufacturer focused on solutions for obstructive sleep apnea. Despite more_horizontal
By GlobeNewsWire
October 3, 2023
Inspire Medical Systems, Inc. to Report Third Quarter 2023 Financial Results on November 7, 2023
MINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quart more_horizontal
By Zacks Investment Research
September 26, 2023
Here's Why You Should Retain Inspire Medical (INSP) Stock Now
Inspire Medical's (INSP) focus on R&D raises optimism about the stock. more_horizontal
By Seeking Alpha
August 16, 2023
Inspire Medical Systems: Excellent Execution And Reset Valuation
Inspire Medical Systems has performed well in 2023 with its hyperglossal nerve stimulation design for sleep apnea sufferers. The company plans to rele more_horizontal
By Seeking Alpha
August 2, 2023
Inspire Medical Systems, Inc. (INSP) Q2 2023 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Ezgi Yagci - Vice President more_horizontal
By Zacks Investment Research
August 1, 2023
Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended June 2023, it could be worth more_horizontal
By Zacks Investment Research
August 1, 2023
Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates
Inspire Medical Systems (INSP) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares more_horizontal